Dennis Peters

7PUBLICATIONS
88CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Tumour immunologyMolecular targetsPsychosocial aspects of childbirth and perinatal mental health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 17, 2026
Pre-existing immunity and hrHPV status determine immunotherapy response in advanced penile cancer: biomarkers and overall survival in the PERICLES trial.

|Jul 24, 2024
Platinum-Based Chemotherapy Induces Opposing Effects on Immunotherapy Response-Related Spatial and Stromal Biomarkers in the Bladder Cancer Microenvironment.

Maksim A Chelushkin, Jeroen van Dorp, Sandra van Wilpe

|Mar 22, 2024
Spatial relationships in the urothelial and head and neck tumor microenvironment predict response to combination immune checkpoint inhibitors.

Alberto Gil-Jimenez, Nick van Dijk, Joris L Vos

|Aug 29, 2023
MYC is a clinically significant driver of mTOR inhibitor resistance in breast cancer.

Jinhyuk Bhin, Julia Yemelyanenko, Xue Chao

|Jul 24, 2023
Atezolizumab With or Without Radiotherapy for Advanced Squamous Cell Carcinoma of the Penis (The PERICLES Study): A Phase II Trial.

Hielke M de Vries, Tynisha S Rafael, Alberto Gil-Jimenez

|Jul 14, 2023
Poor Outcome in Postpartum Breast Cancer Patients Is Associated with Distinct Molecular and Immunologic Features.

Hanne Lefrère, Kat Moore, Giuseppe Floris

Pageof 2

Frequent Collaborators

5 joint publications

Lodewyk Wessels

5 joint publications

Erik Hooijberg

5 joint publications

Annegien Broeks

4 joint publications

Alberto Gil-Jimenez